Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Malignant Melanoma

  Free Subscription


24.07.2017

1 Am J Dermatopathol
1 Cancer Lett
1 Cancer Res
3 Clin Cancer Res
2 J Am Acad Dermatol
1 J Invest Dermatol
1 J Surg Oncol
3 Melanoma Res
1 Ophthalmology


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Dermatopathol

  1. DAVICK JJ, Gaughan E, Barry M, Gru AA, et al
    Primary Cutaneous Small/Medium CD4+ T-CELL Lymphoproliferative Disorder Occurring in a Patient With Metastatic Melanoma.
    Am J Dermatopathol. 2017 Jul 14. doi: 10.1097/DAD.0000000000000960.
    PubMed     Text format     Abstract available


    Cancer Lett

  2. BORST A, Haferkamp S, Grimm J, Rosch M, et al
    Involvement of the BH3-only pro-apoptotic BIK/NBK in BRAF/MEK inhibitor induced apoptosis in melanoma cell lines.
    Cancer Lett. 2017 Jul 15. pii: S0304-3835(17)30431.
    PubMed     Text format     Abstract available


    Cancer Res

  3. HU Y, Lu L, Xia Y, Chen X, et al
    Therapeutic efficacy of cancer stem cell vaccines in the adjuvant setting.
    Cancer Res. 2016 Jun 20. pii: canres.2664.2015.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  4. NIESSNER H, Sinnberg T, Kosnopfel C, Smalley KSM, et al
    BRAF inhibitors amplify the pro-apoptotic activity of MEK inhibitors by inducing ER stress in NRAS-mutant melanoma.
    Clin Cancer Res. 2017 Jul 19. pii: clincanres.0098.2017.
    PubMed     Text format     Abstract available

  5. KAKAVAND H, Rawson RV, Pupo GM, Yang JYH, et al
    PD-L1 expression and immune escape in melanoma resistanceto MAPK inhibitors.
    Clin Cancer Res. 2017 Jul 19. pii: clincanres.1688.2016.
    PubMed     Text format     Abstract available

  6. BAI X, Kong Y, Chi Z, Sheng X, et al
    MAPK pathway and TERT promoter gene mutation pattern and its prognostic value in melanoma patients a retrospective study of 2793 cases.
    Clin Cancer Res. 2017 Jul 18. pii: clincanres.0980.2017.
    PubMed     Text format     Abstract available


    J Am Acad Dermatol

  7. MILLER CJ, Shin TM, Sobanko JF, Sharkey JM, et al
    Risk factors for positive or equivocal margins after wide local excision of 1345 cutaneous melanomas.
    J Am Acad Dermatol. 2017;77:333-340.
    PubMed     Text format     Abstract available

  8. VOLPE VO, Klufas DM, Hegde U, Grant-Kels JM, et al
    The new paradigm of systemic therapies for metastatic melanoma.
    J Am Acad Dermatol. 2017;77:356-368.
    PubMed     Text format     Abstract available


    J Invest Dermatol

  9. SFECCI A, Dupuy A, Dinulescu M, Droitcourt C, et al
    Do the Side Effects of BRAF Inhibitors Mimic RASopathies?
    J Invest Dermatol. 2017;137:805-809.
    PubMed     Text format     Abstract available


    J Surg Oncol

  10. DURHAM AB, Schwartz JL, Lowe L, Zhao L, et al
    The natural history of thin melanoma and the utility of sentinel lymph node biopsy.
    J Surg Oncol. 2017 Jul 17. doi: 10.1002/jso.24765.
    PubMed     Text format     Abstract available


    Melanoma Res

  11. SOSSAU D, Kofler L, Eigentler T
    Type 1 diabetes mellitus caused by treatment with low-dose interferon-alpha in a melanoma patient.
    Melanoma Res. 2017 Jul 19. doi: 10.1097/CMR.0000000000000381.
    PubMed     Text format     Abstract available

  12. BORGHI A, Corazza M, Virgili A, Lambertini AG, et al
    Impact of socioeconomic status and district of residence on cutaneous malignant melanoma prognosis: a survival study on incident cases between 1991 and 2011 in the province of Ferrara, northern Italy.
    Melanoma Res. 2017 Jul 18. doi: 10.1097/CMR.0000000000000378.
    PubMed     Text format     Abstract available

  13. GRATZ V, Luttmann N, Haase O, Langan EA, et al
    Meningeal melanomatosis following discontinuation of dabrafenib: implications for the maintenance of long-term complete remission.
    Melanoma Res. 2017 Jul 18. doi: 10.1097/CMR.0000000000000373.
    PubMed     Text format     Abstract available


    Ophthalmology

  14. SKALET AH, Li Y, Lu CD, Jia Y, et al
    Optical Coherence Tomography Angiography Characteristics of Iris Melanocytic Tumors.
    Ophthalmology. 2016 Nov 14. pii: S0161-6420(16)31328.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: